Intellectual property related to the Australian Life Sciences sector

Compiled by Stuart Roberts, Senior Analyst, stuart@ndfresearch.com, +61 447 247 909 (3 October 2017)

The US Patent Office issues new patents every Tuesday. Australian assignees generally get two or three healthcare and biotech-related patents a week while New Zealand assignees get one every three or four weeks.

Australian grants

Here are the 137 US patents relevant to Australia's Life Sciences sector that were granted in 2014, for an issuance rate of 2.6 per week:

US Patent 8,921,414, Spiroketals, EcoBiotics Ltd, 30 December 2014
US Patent 8,921,374, Itraconazole compositions and dosage forms, and methods of using the same, Mayne Pharma (ASX: MYC), 30 December 2014
US Patent 8,921,309, Lipopeptide compounds and their use, Uniquest Pty Ltd, 30 December 2014
US Patent 8,921,306, Nociceptin mimetics, University of Queensland, 30 December 2014
US Patent 8,920,851, Treatment of neurodegenerative diseases, Velacor Therapeutics, 30 December 2014
US Patent 8,920,806, Method of modulating inflammatory response by downregulation of activin, Paranta Biosciences, 30 December 2014
US Patent 8,920,803, Immunotherapeutic method involving CD123 (IL-3R.alpha.) antibodies and immunostimulating complex, CSL Ltd (ASX: CSL) , 30 December 2014
US Patent 8,916,523, VIP fragments and methods of use, Vectus Biosystems (ASX: VBS), 23 December 2014
US Patent 8,916,166, Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease, Oral Health CRC, 23 December 2014
US Patent 8,912,225, VEGF inhibition, PharmAust (ASX: PAA), 16 December 2014
US Patent 8,911,997, Mammalian cell culture medium, Queensland University of Technology, 16 December 2014
US Patent 8,911,745, Immunology treatment for biofilms, Oral Health CRC, 16 December 2014
US Patent 8,906,919, Treatment of non-neuronal and non-myocardial cell, tissue and organ damage and associated pain with persistent sodium current blockers, Ozteo Pty Ltd, 9 December 2014
US Patent 8,906,912, Anxiolytic compounds, Bionomics (ASX: BNO), 9 December 2014
US Patent 8,906,279, Humanized antibodies with anti-tumor activity, Teva Pharmaceuticals Australia, 2 December 2014
US Patent 8,895,698, Binding partners of antibodies specific for dendritic cell antigens, Mater Hospital Brisbane, 25 November 2014
US Patent 8,895,019, Biofilm treatment, Oral Health CRC, 25 November 2014
US Patent 8,889,695, Quinazolinone compounds, Prana Biotechnology (ASX: PBT), 18 November 2014
US Patent 8,883,015, Patch production, University of Queensland, 11 November 2014
US Patent 8,877,727, Delivery of dsRNA to arthropods, Commonwealth Scientific and Industrial Research Organisation, 4 November 2014
US Patent 8,877,243, Cross-linked polysaccharide composition, Ultraceuticals, 4 November 2014
US Patent 8,871,709, Synthetic chimeric proteins comprising epidermal growth factor and vitronectin, Queensland University of Technology, 28 October 2014
US Patent 8,871,272, Layered nanoparticles, Australian Nuclear Science & Technology Organisation, 28 October 2014
US Patent 8,871,272, Probiotic storage and delivery, Commonwealth Scientific and Industrial Research Organisation, 28 October 2014
US Patent 8,871,213, Prevention, treatment and diagnosis of P. gingivalis infection, Oral Health CRC, 28 October 2014
US Patent 8,865,736, Antibacterial agents, Biota, 21 October 2014
US Patent 8,859,627, Anti-microbial composition, Wild Child, 14 October 2014
US Patent 8,858,951, Compositions for eliciting an immune response, University of Queensland, 14 October 2014
US Patent 8,858,939, Ectopic pregnancy treatment, Monash University, 14 October 2014
US Patent 8,252,641, Polymer microgel beads and preparative method thereof, University of Sydney, 7 October 2014
US Patent 8,846,026, Composition comprising immunogenic microparticles, PX BioSolutions, 30 September 2014
US Patent 8,841,420, Synthetic peptide constructs for the diagnosis and treatment of periodontis associated with Porphyromonas gingivalis, University of Melbourne, 23 September 2014
US Patent 8,841,351, Polymeric topical compositions, Stiefel Research Australia, 23 September 2014
US Patent 8,841,342, Carrier, Vital Health Sciences (Simon West), 23 September 2014
US Patent 8,841,254, Method for treatment of anxiety, Florey Institute of Neuroscience and Mental Health, 23 September 2014
US Patent 8,835,629, Anti-cancer agents, Walter and Eliza Hall Institute, 16 September 2014
US Patent 8,835,609, Antigen binding sites to non-functional oligomeric P2X7 receptors and methods of use thereof, Biosceptre International, 16 September 2014
US Patent 8,835,478, Treatment for cancer, PharmAust (ASX: PAA), 16 September 2014
US Patent 8,834,872, Uses of antibodies, Antony Scammell, 16 September 2014
US Patent 8,828,933, Mutant Tat proteins and uses thereof, Queensland Institute of Medical Research, 9 September 2014
US Patent 8,828,435, Buccal delivery system, Lingual Consegna Pty Ltd, 9 September 2014
US Patent 8,828,409, Vaccine comprising recombinant CLPP protein of Streptococcus pneumoniae, Adelaide Research & Innovation with Sungkyunkwan University (Korea), 9 September 2014
US Patent 8,822,644, Method of treating cancer comprising a VEGF-B antagonist, CSL Ltd (ASX: CSL), 2 September 2014
US Patent 8,822,509, Pain-relieving compositions and uses therefor, University of Queensland, 2 September 2014
US Patent 8,822,416, Topical analgesic composition, Animal Ethics Pty Ltd, 2 September 2014
US Patent 8,822,409, Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ARDS) and clinical disorders associated with therewith, Phylogica (ASX: PYC), 2 September 2014
US Patent 8,815,936, Pharmaceutical formulations of resveratrol and methods of use thereof for treating cell disorders, NAD Life, 26 August 2014
US Patent 8,815,298, Therapeutic composition comprising honey or a honey derivative, Medihoney Pty Ltd, 26 August 2014
US Patent 8,815,291, Particles comprising a releasable dopant therein, Australian Nuclear Science & Technology Organisation, 26 August 2014
US Patent 8,809,386, Use of dynamin ring stabilizers, Children's Medical Research Institute with MassGeneral (US), 19 August 2014
US Patent 8,809,301, Surgical hydrogel, Adelaide Research & Innovation with Robinson Squidgel Ltd and (NZ) and University of Otago (NZ), 19 August 2014
US Patent 8,808,751, Methods for the preparation of biologically active compounds in nanoparticulate form, iCeutica, 19 August 2014
US Patent 8,808,716, Topical foam composition, Stiefel Research Australia, 19 August 2014
US Patent 8,808,706, Arthrospira-based compositions and uses thereof, Biovite Australia, 19 August 2014
US Patent 8,808,692, Compositions comprising immunoreactive reagents and saponins, and methods of use thereof, CSL Ltd (ASX: CSL) , 19 August 2014
US Patent 8,807,861, Spreading implement, Acrux (ASX: ACR), 19 August 2014
US Patent 8,802,840, Bicyclic nucleosides and nucleotides as therapeutic agents, Biota, 12 August 2014
US Patent 8,802,634, CD40-L inhibitory peptides, Phylogica (ASX: PYC), 12 August 2014
US Patent 8,802,625, Methods for promoting organ development, Kintan Pty Ltd, 12 August 2014
US Patent 8,802,408, Process for preparing nutritional, therapeutic or organoleptic products from crude glycerol, Bio Processing Australia, 12 August 2014
US Patent 8,802,135, Delivery system for remote treatment of an animal, Smartvet Pty Ltd, 12 August 2014
US Patent 8,802,116, Poloxamer emulsion preparations, Novasel Pty Ltd (Steen Jorsal), 12 August 2014
US Patent 8,796,273, Compound for the treatment of enteroviruses, Biota, 5 August 2014
US Patent 8,796,225, Regulation of immune responses by modulation of the function of antigen presenting cells, Invion (ASX: IVX), 5 August 2014
US Patent 8,790,909, Strains of Helicobacter pylori and uses thereof, Ondek, 29 July 2014
US Patent 8,790,889, Neuronal stimulation, University of Queensland, 29 July 2014
US Patent 8,785,478, Viral polymerase inhibitors, Biota, 22 July 2014
US Patent 8,785,140, CD4+ CD25+ T-cells activated to a specific antigen, University of New South Wales, 22 July 2014
US Patent 8,784,878, Transdermal delivery rate control using amorphous pharmaceutical compositions, Acrux (ASX: ACR), 22 July 2014
US Patent 8,784,831, P. gingivalis antigenic composition, CSL Ltd (ASX: CSL) with University of Melbourne, 22 July 2014
US Patent 8,779,107, Composition for targeting dendritic cells, Lipotek with GSK (UK), 15 July 2014
US Patent 8,778,400, Nanoparticle-stabilized capsule formulation for treatment of inflammation, University of South Australia, 15 July 2014
US Patent 8,778,300, Method of forming an injectable radioactive composition of a carbon encapsulated radioactive particulate, Australian National University, 15 July 2014
US Patent 8,772,013, Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells, EnGeneIC, 8 July 2014
US Patent 8,771,764, Composition and method for improving vascular health, Commonwealth Scientific and Industrial Research Organisation with the Malaysian Palm Oil Board (Malaysia), 8 July 2014
US Patent 8,771,739, Pharmaceutical compositions for poorly soluble drugs, Mayne Pharma (ASX: MYC), 8 July 2014
US Patent 8,771,701, Compositions for immunotherapy and uses thereof, Burnet Institute, 8 July 2014
US Patent 8,765,812, Therapeutic compounds, Fibrotech Therapeutics, 1 July 2014
US Patent 8,765,700, Topical administrations of antisense compounds to VLA-4 for the treatment of respiratory conditions, Antisense Therapeutics (ASX: ANP), 1 July 2014
US Patent 8,765,677, Omega conotoxin peptides, University of Queensland with University of Sydney, 1 July 2014
US Patent 8,765,183, Polymer microgel beads, University of Sydney, 1 July 2014
US Patent 8,765,163, Biocompatible material and uses thereof, University of Sydney, 1 July 2014
US Patent 8,765,144, Antigenic complex for the diagnosis and treatment of Porphyromonas gingivalis infection, University of Melbourne, 1 July 2014
US Patent 8,759,286, Pharmaceutical compositions comprising a VEGF-D polypeptide, Opthea (ASX: OPT), 24 June 2014
US Patent 8,758,728, Foamable suspension gel, Stiefel Research Australia, 24 June 2014
US Patent 8,748,406, Preventive for adhesion following abdominal surgery, Cellmid (ASX: CDY), 10 June 2014
US Patent 8,747,830, Wound repair composition and method, Queensland University of Technology, 10 June 2014
US Patent 8,741,970, Composition and method for the enhancement of the efficacy of drugs, Alchemia (ASX: ACL), 3 June 2014
US Patent 8,741,296, Adenocarcinoma specific antibody SAM-6, and uses thereof, Patrys (ASX: PAB), 3 June 2014
US Patent 8,735,566, Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells, EnGeneIC, 27 May 2014
US Patent 8,735,173, Multiplex screening for lysosomal storage disorders (LSDS), Women's and Children's Hospital, Adelaide, 27 May 2014
US Patent 8,729,020, Methods for the treatment of aortic fibrosis with VIP fragments, Vectus Biosystems (ASX: VBS), 20 May 2014
US Patent 8,728,512, Treatment and composition for wound healing, Professor Christopher Jackson, 20 May 2014
US Patent 8,722,675, Method of treatment or prophylaxis, Spinifex Pharmaceuticals, 13 May 2014
US Patent 8,722,634, Use of compounds extracted from Momordica charantia L. in the manufacture of medicaments for prevention and treatment of diabetes and obesity, Garvan Institute of Medical Research with the Shanghai Institute of Materia Medica, Chinese Academy of Sciences (China), 13 May 2014
US Patent 8,722,036, Methods for treating malignancies using coxsackieviruses, Viralytics (ASX: VLA), 13 May 2014
US Patent 8,716,335, Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors, Bionomics (ASX: BNO), 6 May 2014
US Patent 8,716,222, Methods and compositions for promoting organ development, Kintan Pty Ltd, 6 May 2014
US Patent 8,715,724, Tabletting process, Mayne Pharma (ASX: MYC), 6 May 2014
US Patent 8,710,015, Tropoelastin derivatives, University of Sydney, 29 April 2014
US Patent 8,709,486, Administrable compositions, University of Sydney, 29 April 2014
US Patent 8,709,425, Antibodies to non-functional P2X7 receptor, Biosceptre International, 29 April 2014
US Patent 8,703,147, Methods and compositions for treating and preventing malaria, Walter and Eliza Hall Institute, 22 April 2014
US Patent 8,703,116, Modified macromolecule, Starpharma (ASX: SPL), 22 April 2014
US Patent 8,697,702, Method of optimizing the treatment of Philadelphia-positive leukemia with imatinib mesylate, Medvet Science Pty Ltd with Novartis (Switerland) , 15 April 2014
US Patent 8,697,678, Anaesthetic formulation, Drawbridge Pharmaceuticals, 15 April 2014
US Patent 8,697,145, Substances having body mass redistribution properties, Horizon Science Pty Ltd (David Kannar and Barry Kitchen), 15 April 2014
US Patent 8,691,967, Multiple promoter expression cassettes for simultaneous delivery of RNAi agents, Benitec (ASX: BLT), 8 April 2014
US Patent 8,691,963, Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells, EnGeneIC, 8 April 2014
US Patent 8,691,765, Metallothionein based neuronal therapeutic and therapeutic methods, University of Tasmania, 8 April 2014
US Patent 8,686,110, Therapeutic pro-apoptotic BH3-like molecules and methods for generating and/or selecting the same, Walter and Eliza Hall Institute, 1 April 2014
US Patent 8,685,473, Pawpaw and/or peach derived composition, Phoenix Eagle, 1 April 2014
US Patent 8,680,141, Spiroketals, EcoBiotics, 25 March 2014
US Patent 8,680,135, Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors, Bionomics (ASX: BNO), 25 March 2014
US Patent 8,673,872, Method of modulation of expression of epidermal growth factor receptor(EGFR) involving miRNA, University of Western Australia, 18 March 2014
US Patent 8,673,586, Compounds that interact with kinases, Alchemia (ASX: ACL), 18 March 2014
US Patent 8,673,367, Nano silver-zinc oxide composition, Polymers CRC, 18 March 2014
US Patent 8,673,363, Dental mineralization, University of Melbourne, 18 March 2014
US Patent 8,673,361, Cytokine modulating composition, Cambridge Scientific Pty Ltd (Maud Eijkenboom), 18 March 2014
US Patent 8,673,305, Methods of treatment with antibodies against the extracellular loops of C5aR, G2 Therapies, 18 March 2014
US Patent 8,669,280, Antiviral compounds and methods, Biotron (ASX: BIT), 11 March 2014
US Patent 8,669,101, Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells, EnGeneIC, 11 March 2014
US Patent 8,653,236, Therapeutic agents, Inter-K Pty Ltd, 18 February 2014
US Patent 8,652,511, Transdermal delivery patch, Phosphagenics (ASX: POH), 18 February 2014
US Patent 8,652,473, Antibodies to EGF receptor epitope peptides and uses thereof, Commonwealth Scientific and Industrial Research Organization with the Ludwig Institute for Cancer Research (US) and Massachusetts Institute of Technology (US), 18 February 2014
US Patent 8,642,731, Porphyromonas gingivalis polypeptides and nucleotides, CSL Ltd (ASX: CSL) with University of Melbourne, 4 February 2014
US Patent 8,642,631, Methods of treating mammals with eustachian tube dysfunctions, University of Melbourne, 4 February 2014
US Patent 8,637,262, Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof, Opthea (ASX: OPT), 28 January 2014
US Patent 8,637,051, Compositions and methods for treatment of mucosal infections, Hunter Immunology, 28 January 2014
US Patent 8,637,025, Composition and method for the treatment and prevention of enteric bacterial infections, Immuron (ASX: IMC), 28 January 2014
US Patent 8,637,016, EphA3 antibodies for the treatment of solid tumors, Monash University with KaloBios Pharmaceuticals (US) and the Ludwig Institute for Cancer Research (US , 28 January 2014
US Patent 8,629,318, Transgenic animals for analyzing CYP3A4 cytochrome P450 gene regulation, University of Sydney, 14 January 2014
US Patent 8,629,241, Alpha helical mimics, their uses and methods for their production, University of Queensland, 14 January 2014
US Patent 8,628,761, Biodegradable polyurethane/urea compositions, Polynovo (ASX: PNV), 14 January 2014
US Patent 8,624,025, Antiviral agents, Biota, 7 January 2014
US Patent 8,623,836, Modulation of growth hormone receptor expression and insulin-like growth factor expression, Antisense Therapeutics and Isis Pharmaceuticals, 7 January 2014
US Patent 8,623,354, Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment, Alchemia (ASX: ACL), 7 January 2014

New Zealand applications

Here are the 15 US patents relevant to New Zealand's Life Sciences sector that were granted in 2014, for an issuance rate of 0.2 applications per week:

US Patent 8,889,636, Anti-microbial compositions, Biotelliga, 18 November 2014
US Patent 8,877,465, Production of ultrapure EPA and polar lipids from largely heterotrophic culture, Photonz, 4 November 2014
US Patent 8,835,397, Macrocyclic lactone tablet formulation, Bayer New Zealand, 16 September 2014
US Patent 8,821,921, Vitamin D3 for the transdermal treatment of pain and inflammation, Anzamed International (Dr John Lyftogt), 2 September 2014
US Patent 8,809,301, Surgical hydrogel, Robinson Squidgel Ltd with University of Otago and Adelaide Research & Innovation (Australia), 19 August 2014
US Patent 8,791,117, Cyclic glycyl-2-allyl proline improves cognitive performance in impaired animals, Neuren Pharmaceuticals (ASX: NEU), 29 July 2014
US Patent 8,784,795, Methods for determining personalized treatment compositions for prostate cancer and breast cancer, Caldera Health, 22 July 2014
US Patent 8,758,781, Tissue scaffolds derived from forestomach extracellular matrix, Aroa Biosurgery, 24 June 2014
US Patent 8,709,448, Anti-infective agents and uses thereof, Innate Immunotherapeutics (ASX: IIL), 29 April 2014
US Patent 8,703,699, Lactoferrin, Auckland UniServices (University of Auckland), 22 April 2014
US Patent 8,679,527, Antimicrobial compositions, Manuka Health, 25 March 2014
US Patent 8,669,084, Functional lipid constructs, Kode Biotech, 11 March 2014
US Patent 8,637,567, Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamic acid, Neuren Pharmaceuticals (ASX: NEU), 28 January 2014
US Patent 8,637,473, Synthetic membrane anchors, Kode Biotech, 28 January 2014
US Patent 8,633,248, Parenteral selenomethionine for production of selenium-rich foods, AgResearch Ltd, 21 January 2014